BOOST Pharma ApS
CVR 41120495 · Private limited company (ApS) · Active · High risk
BOOST Pharma ApS is a Private limited company (ApS), founded on , based in Frederiksberg. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 3.4% over the next 12 months, which is 2.4 times the average for Danish companies. 6 annual reports have been published, of which 1 more than six months after the end of the financial year. The latest annual report (31 Dec 2025) shows equity of DKK -11.9m and a net result of DKK -9.2m.
Bankruptcy risk for BOOST Pharma ApS
2.4 × the average (1.41%) · higher risk than 88% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 41120495
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (6 years)
- Address
- Nordre Fasanvej 215
2000 Frederiksberg - Municipality
- Frederiksberg
- Industry
- Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik - Share capital
- DKK 55k
- Auditor
- AIDER Godkendt Revisionsaktieselskab
- Audit opted out
- No
Warning signs
| Annual reports filed late | 1 of 6 |
| Missing annual report | No |
| Negative equity | Yes |
| Equity ratio | -164.4% |
| Current ratio | 392% |
| Moves (last 2 years) | 1 |
| CEO changes in total | 7 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 111 |
| Going-concern uncertainty | Yes |
Financials and key figures
| Financial year | 2025 | 2024 |
|---|---|---|
| Gross profit | DKK -7.6m | DKK -2.2m |
| Net profit | DKK -9.2m | DKK -4.3m |
| Equity | DKK -11.9m | DKK -7.0m |
| Total assets | DKK 7.2m | DKK 7.6m |
| Cash | DKK 5.4m | – |
| Short-term debt | DKK 1.8m | – |
| Avg. employees | 2 | – |
Latest annual report: Reporting class B · auditor's statement: Revisionspåtegning · Baker Tilly Denmark.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 175 | ||
| 1 Jan 2024 – 31 Dec 2024 | 146 | ||
| 1 Jan 2023 – 31 Dec 2023 | 186 | Late | |
| 1 Jan 2022 – 31 Dec 2022 | 170 | ||
| 1 Jan 2021 – 31 Dec 2021 | 81 | ||
| 20 Jan 2020 – 31 Dec 2020 | 85 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Lilian Karin Florence Walter Jallow | ||
| CEO | Anna Cecilia Götherström | ||
| CEO | Lars Magnus Reinhold Westgren | ||
| CEO | Ingelise Saunders | ||
| CEO | Everhardus Johannes Joseph Kueppers | ||
| Board | Ingelise Saunders | ||
| Board | Lars Magnus Reinhold Westgren | ||
| Board | Jonathan Jossi Ilicki | ||
| Board | John Öhd | ||
| Board | Jonas Jendi | ||
| Board | Jonathan Jossi Ilicki | ||
| Board | Hans Thalsgård Schambye | ||
| Owner (100%) | BOOST Pharma AB | Current | |
| Owner (25%) | Lilian Karin Florence Walter Jallow | ||
| Owner (25%) | Anna Cecilia Götherström | ||
| Owner (25%) | Lars Magnus Reinhold Westgren | ||
| Owner (5%) | SAUNDERS HOLDING ApS | ||
| Owner (20%) | Westknow AB | ||
| Owner (20%) | Lilian Karin Florence Walter Jallow | ||
| Owner (20%) | Anna Cecilia Götherström | ||
| Owner (10%) | Stiftelsen Industrifonden | ||
| Owner (5%) | Karolinska Development AB | ||
| Owner (10%) | Karolinska Development AB | ||
| Auditor | AIDER Godkendt Revisionsaktieselskab | Current | |
| Founder | Lilian Karin Florence Walter Jallow | Current | |
| Founder | Anna Cecilia Götherström | Current | |
| Founder | Lars Magnus Reinhold Westgren | Current |
The CEOs' other companies
Ingelise Saunders – 27 other companies, of which 1 bankrupt
- ECRON ACUNOVA A/S Bankrupt 9 Jun 2020
- ACESION PHARMA ApS Active
- ACTION PHARMA AF 22. FEBRUAR 2012 A/S Opløst
- ADMINISTRATIONS & SERVICE CENTRET A/S Fusioneret
- ALK-ABELLÓ A/S Active
- ALPHALYSE A/S Active
- AVILEX PHARMA ApS Active
- DEAS A/S Active
- HERMEDICO A/S Fusioneret
- LEO Holding A/S Active
- LEO PHARMA A/S Active
- Life Science Legal ApS Active
- MEDICON VALLEY CAPITAL II GENERAL PARTNER ApS Opløst
- MINERVAX ApS Active
- NORDIC VACCINE A/S Opløst
- NOVO NORDISK FARMAKA DANMARK A/S Opløst
- NOVO NORDISK RESEARCH & DEVELOPMENT A/S Opløst
- NSGENE A/S Opløst
- Opgen ApS Opløst
- SAUNDERS HOLDING ApS Active
- SCANDINAVIAN LIFE SCIENCE INVEST ApS Opløst
- SKOVMARKEN ApS Opløst
- SPKA Ejendom A/S Active
- SPKA Holding A/S Active
- TD VACCINES A/S Opløst
- TOPOTARGET A/S Fusioneret
- UCB NORDIC A/S Active
Address history (1 moves)
| Nordre Fasanvej 215, 2000 Frederiksberg | |
| c/o Bio Innovation Institute, Ole Maaløes Vej 3, 2200 København N |
Other companies at the same address
- Nordetect ApS Bankrupt
- ACESION PHARMA ApS Active
- AdaptVac ApS Active
- Adcendo ApS Active
- Akylox Therapeutics ApS Active
- Antraka ApS Opløst
- Augustine Therapeutics Denmark ApS Active
- Autocert ApS Active
- Avancert ApS Active
- B4C ApS Active
- Baekmark IP Consult ApS Active
- Betula Capital ApS Active
- BioPhenyx ApS Active
- Biobridge Partners ApS Active
- Biotinia ApS Active
- CMCAssist ApS Active
- CMCGreenhouse ApS Active
- CMCHoldings ApS Active
- CaMaRa ApS Active
- Catalyst Vaccination A/S Active
- Chris Cording Jønsson Holding ApS Active
- DARERL ApS Active
- DFY ApS Active
- DeltaBot ApS Active
- Details ApS Active
Similar companies in Frederiksberg
- Catalyst Vaccination A/S Frederiksberg
- RefuelBio ApS Frederiksberg
- BioMomentum Advisors ApS Frederiksberg
- Oak Mountain Consulting ApS Frederiksberg
- Biotinia ApS Frederiksberg
- Nordic BioVentures ApS Frederiksberg C
- Zevra Denmark A/S Frederiksberg
- BioPhenyx ApS Frederiksberg
- BioSpringbok ApS Frederiksberg
- Orbis Medicines ApS Frederiksberg
- Epoqe Pharma ApS Frederiksberg
- SJM IP ApS Frederiksberg C
Questions and answers about BOOST Pharma ApS
Has BOOST Pharma ApS gone bankrupt?
No, BOOST Pharma ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of BOOST Pharma ApS?
Our model estimates a bankruptcy risk of 3.4% over the next 12 months (high risk), which is 2.4 times the average for Danish companies.
Who is the auditor of BOOST Pharma ApS?
BOOST Pharma ApS most recently used AIDER Godkendt Revisionsaktieselskab.
When was BOOST Pharma ApS founded?
BOOST Pharma ApS was founded on 20 January 2020.
What is the equity of BOOST Pharma ApS?
Equity was DKK -11.9m according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.